scleroderma: Scleroderma is a rare autoimmune connective tissue disorder characterized by abnormal hardening of the skin and, sometimes, other organs. It is classified into two main forms: localized scleroderma and systemic sclerosis (SSc), the latter comprising three subsets; diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc) and limited SSc (lSSc) (see these terms).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
867 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
323 |
4. Check minimum number of eventsNone |
323 |
5. Include endpointsNone |
323 |
6. Filter based on genotype QC (FinnGen only) |
323 |
Control definitions (FinnGen only)
- Control conditions
- not SYSTSCLE_ICD10
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Systemic sclerosis,strict definition
based on the number of shared cases.
Similar with more cases:
- Systemic sclerosis, icd10
- Systemic sclerosis (FG)
- Systemic sclerosis
- Systemic connective tissue disorders
- Reimbursement for rheumatic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1154 | 971 | 174 |
| Only index persons | 1108 | 946 | 162 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.00 |
| Only index persons | 0.03 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 56.01 | 56.13 | 55.70 |
| Only index persons | 55.73 | 55.79 | 55.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 323 | 280 | 43 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.02 |
| Median age at first event (years) | 54.65 | 54.38 | 56.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 270
- Matched controls
- 2700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
264.0
270
173
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
247.7
198
*
P01BA02
ATC
hydroxychloroquine; oral
45.5
139.6
183
119
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
2201.8
138.1
122
*
C08CA05
ATC
nifedipine; systemic
55.3
129.1
155
64
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
27.2
110.1
169
156
I73.0
ICD-10 Finland
Raynaud syndrome
73.1
79.7
89
18
XX9XE
NOMESCO Finland
Other ultrasound examination
121.8
68.9
72
8
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
55.1
51
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
12.1
48.9
97
119
XPX04
NOMESCO Finland
Angioscopy
106.9
48.8
52
6
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
10.8
44.6
94
127
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
49.1
43.5
52
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.3
43.3
190
736
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.2
41.7
157
495
L04AA06
ATC
mycophenolic acid; systemic
29.7
40.8
55
23
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
17.1
39.9
65
49
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
15.3
39.1
67
57
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
206.7
35.7
36
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
35.2
33
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.6
31.8
112
301
L04AX01
ATC
azathioprine; systemic
12.1
27.8
52
52
L88
ICPC
Rheumatoid/seropositive arthritis
12.2
26.4
49
48
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
143.2
25.1
26
*
XG410
NOMESCO Finland
Flow-volume spirometry
12.6
23.7
43
40
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
17.3
22.2
35
23
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.5
21.5
39
36
G04BE03
ATC
sildenafil; oral
39.1
20.2
25
7
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
10.5
20.2
40
44
C08CA02
ATC
felodipine; oral
6.1
19.9
58
116
H02AB06
ATC
prednisolone; systemic
3.3
19.8
172
929
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
32.7
18.7
24
8
C08CA01
ATC
amlodipine; oral
3.3
17.6
121
537
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
17.4
137
667
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.9
17.0
60
149
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.8
16.6
49
99
NH3EA
NOMESCO Finland
Feet X-ray examination with load
14.1
16.6
28
22
L04AD01
ATC
ciclosporin; systemic
16.8
16.6
26
17
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
13.4
16.3
28
23
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
14.7
14
*
M34
ICD-10 Finland
Systemic sclerosis
+∞
14.7
14
*
R4120
NOMESCO Finland
Occupational therapy
5.4
14.0
43
91
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
5.0
13.6
45
103
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
27.4
13.5
18
7
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.6
13.5
49
124
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.8
13.2
28
35
WZA10
NOMESCO Finland
Long statement of health and health related matters
15.1
13.0
21
15
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
15.1
13.0
21
15
RT172
NOMESCO Finland
NA
73.4
12.7
14
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.2
12.7
50
137
RT160
NOMESCO Finland
NA
136.1
12.5
13
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
136.1
12.5
13
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
9.9
11.8
23
25
M35.1
ICD-10 Finland
Other overlap syndromes
68.0
11.7
13
*
E0000UV
ATC
NA
2.5
11.7
142
833
RT274
NOMESCO Finland
NA
62.5
10.7
12
*
C02KX01
ATC
bosentan; oral
114.3
10.5
11
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
8.0
10.4
23
31
C02KX04
ATC
macitentan; oral
41.7
10.0
12
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
27.2
9.9
13
5
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
12.0
9.7
17
15
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
9.6
60
234
RT272
NOMESCO Finland
NA
103.5
9.5
10
*
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
14.4
9.3
15
11
L04AA01
ATC
[U] ciclosporin; systemic
13.2
9.0
15
12
A02BC02
ATC
pantoprazole; systemic
2.3
8.7
193
1421
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.5
8.6
16
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
8.6
135
850
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
8.6
35
99
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
8.5
23
42
RT271
NOMESCO Finland
NA
92.8
8.5
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.8
8.4
36
106
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
8.4
8
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.9
8.4
34
96
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.2
80
403
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.9
8.1
33
93
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.7
7.9
26
60
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
7.6
58
253
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.2
7.4
27
69
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
8.8
7.4
15
18
SPAT1263
SPAT
Sampling
2.1
7.4
125
798
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
7.4
131
852
RT231
NOMESCO Finland
NA
+∞
7.3
7
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
11.3
6.9
12
11
I27.0
ICD-10 Finland
Primary pulmonary hypertension
41.1
6.8
8
*
A02BC05
ATC
esomeprazole; systemic
2.0
6.6
131
879
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.2
6.5
33
112
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
6.5
77
417
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.8
6.4
15
23
UJF32
NOMESCO Finland
Coloscopy
2.1
6.3
81
455
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
6.3
6
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
6.3
6
*
L94.3
ICD-10 Finland
Sclerodactyly
+∞
6.3
6
*
K62.3
ICD-10 Finland
Rectal prolapse
8.9
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
154
94
30.40
196.90
1.6
1.2
u/ml
2.4
2.7
0.12
51
12
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
154
95
30.07
195.90
1.7
1.2
u/ml
7.1
7.9
0.05
72
19
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
157
105
28.15
192.17
1.6
1.2
u/ml
3.6
3.1
—
11
8
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
121
79
23.89
147.25
1.6
1.2
u/ml
24.0
28.3
0.08
26
11
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
116
75
23.57
141.51
1.6
1.2
u/ml
0.5
—
—
5
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
268
680
18.27
125.76
5.3
3.1
ng/l
561.9
863.1
1.75
252
570
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
120
114
16.16
117.44
2.5
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
123
123
15.54
116.53
1.7
1.3
u/ml
8.2
1.2
—
16
9
(3037522) Nuclear Ab [Titer] in Serum
206
436
11.28
109.59
1.8
1.4
titre
2180.5
414.8
23.51
158
100
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
56
11
61.38
99.00
2.6
1.2
ug/l
8.3
8.9
0.17
56
11
(3001604) Monocytes [#/volume] in Blood
314
1378
46.89
93.58
14.3
5.7
e9/l
0.6
0.5
0.27
309
1205
(3006315) Basophils [#/volume] in Blood
314
1385
46.48
93.03
14.5
5.7
e9/l
0.0
0.0
1.54
309
1210
(3019198) Lymphocytes [#/volume] in Blood
315
1411
50.80
92.27
14.4
5.7
e9/l
1.6
2.0
3.76
309
1261
(3013115) Eosinophils [#/volume] in Blood
315
1436
49.23
90.20
14.6
6.1
e9/l
0.2
0.2
0.93
310
1281
(3013650) Neutrophils [#/volume] in Blood by Automated count
314
1606
35.28
75.17
17.9
9.2
e9/l
3.7
4.0
1.76
307
1417
(40759836) Histone Ab [Presence] in Serum by Immunoblot
47
27
20.20
58.67
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
47
27
20.20
58.67
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
47
27
20.20
58.67
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
47
28
19.47
57.66
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
47
28
19.47
57.66
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
47
28
19.47
57.66
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
225
879
6.14
54.50
13.0
5.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
212
796
5.84
53.57
2.9
2.2
u/l
93.2
144.2
4.00
205
759
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
40
29
15.60
44.12
1.4
1.2
u/ml
9.6
72.2
—
9
5
(3038026) Centromere Ab [Units/volume] in Serum
40
29
15.60
44.12
1.4
1.2
u/ml
102.1
—
—
14
0
(3004616) Nuclear Ab [Presence] in Serum
44
42
11.97
41.10
1.5
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
48
56
9.89
38.89
1.7
2.1
g/l
125.1
131.2
0.58
16
39
(3035350) Ketones [Presence] in Urine by Test strip
259
1352
5.62
38.68
5.7
3.5
estimate
0.0
0.0
0.00
64
268
(3021601) Nitrite [Presence] in Urine by Test strip
257
1372
5.27
36.21
7.3
4.6
estimate
0.0
0.0
0.00
67
269
(40760892) CBC W Ordered Manual Differential panel - Blood
169
670
4.19
36.08
8.8
4.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
258
1389
5.26
35.74
5.8
3.5
estimate
0.0
0.0
0.50
68
264
(3013293) Extractable nuclear Ab [Presence] in Serum
38
5
85.54
34.67
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
93
253
4.76
32.53
2.3
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
152
606
3.85
31.23
6.3
3.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
81
205
4.94
30.85
5.6
4.2
%
0.6
0.4
0.35
16
40
(3025159) Blasts/100 leukocytes in Blood
80
201
4.96
30.73
6.3
4.3
%
0.0
0.0
0.00
16
43
(3021440) Promyelocytes/100 leukocytes in Blood
82
211
4.87
30.59
6.3
4.3
%
0.2
0.2
0.12
21
53
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
313
2127
16.23
29.43
14.5
7.1
u/l
72.4
76.3
1.39
313
1981
(3026493) Urate [Moles/volume] in Serum or Plasma
159
675
3.67
29.30
3.1
2.5
umol/l
317.1
6193.1
2.99
152
578
(3037467) Urinalysis macro (dipstick) panel - Urine
293
1879
7.02
29.27
8.4
4.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
84
229
4.61
29.05
6.3
4.1
%
0.9
1.0
0.06
22
62
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
15
17.20
28.27
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
228
1256
3.77
27.21
18.9
8.5
e9/l
0.0
0.0
0.05
218
1039
(3018095) Leukocytes [#/volume] in Urine
185
912
3.41
26.03
4.1
3.4
e6/l
31.0
62.2
0.98
126
622
(40768797) Stomach Pathology biopsy report
108
402
3.53
23.59
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
43
80
6.05
22.81
1.6
1.7
iu/ml
0.0
0.1
—
5
7
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
52
6.95
20.51
3.1
3.4
e9/l
3.8
4.9
1.31
33
52
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
53
6.82
20.15
3.1
3.8
%
56.4
59.4
0.62
33
53
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
207
1203
3.01
20.02
3.0
2.3
nmol/l
78.9
77.7
0.29
198
1077
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
212
1291
2.87
18.03
8.7
6.0
mmol/l
1.2
1.2
2.78
181
1084
(3029937) Albumin [Presence] in Urine by Test strip
148
754
2.78
17.80
7.1
3.7
estimate
0.0
0.0
0.00
68
268
(3000850) Epithelial cells [#/volume] in Urine
113
520
2.80
16.28
2.6
2.4
e6/l
4.2
7.0
0.87
106
464
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
194
1181
2.61
15.65
7.9
5.2
mmol/l
1.2
1.2
1.78
181
1079
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
95
410
2.87
15.33
2.8
2.4
e6/l
0.8
1.2
1.40
79
231
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
119
579
2.67
15.21
1.3
1.3
iu/ml
26.6
37.9
0.67
51
195
(36304419) Bacteria [Presence] in Urine
133
689
2.58
14.89
3.2
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
133
691
2.57
14.78
3.3
2.7
e6/l
0.1
0.4
1.84
121
507
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
158
902
2.47
14.20
5.0
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
61
215
3.26
13.93
6.9
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
134
716
2.49
13.84
10.5
6.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
146
816
2.44
13.61
4.0
3.6
ph
7.4
7.4
1.44
35
160
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
73
4.76
13.41
2.4
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
82
359
2.72
12.63
2.4
1.9
—
—
—
0
0
(4268621)
20
32
6.60
12.15
2.3
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
173
1080
2.30
12.08
6.6
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
317
2789
8.35
12.07
26.7
12.2
mg/l
17.2
20.6
1.26
263
2155
(3044889) 12 lead EKG panel
257
1922
2.65
11.59
5.9
3.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
41
5.68
11.51
1.3
1.1
u/ml
11.3
1.6
—
7
12
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
114
609
2.35
11.36
3.7
2.1
mg/l
3.6
3.1
1.08
106
518
(3007853) Bacteria identified in Skin by Aerobe culture
67
281
2.75
11.12
2.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
17
8.56
10.69
2.1
1.9
%
15.6
7.7
—
5
11
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
293
2.67
10.68
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
53
4.81
10.42
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
60
247
2.76
10.27
11.7
6.8
mmol/l
0.3
1.3
1.28
46
202
(3007164) IgA [Mass/volume] in Serum or Plasma
109
595
2.26
10.14
1.6
1.4
g/l
2.1
2.3
0.49
77
354
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
245
2.72
9.92
2.2
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
128
751
2.17
9.91
3.2
2.8
e6/l
10.0
41.2
2.14
116
564
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
16
8.42
9.80
2.3
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
206
2.82
9.55
2.5
3.1
e9/l
3.9
4.0
0.19
41
168
(3024561) Albumin [Mass/volume] in Serum or Plasma
164
1079
2.06
9.19
5.7
4.2
g/l
35.7
36.0
0.31
158
1019
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
182
2.85
8.98
1.3
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
25
6.24
8.73
2.0
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
10
10.29
8.68
2.5
1.6
e9/l
0.1
0.3
—
10
10
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
19
7.09
8.50
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
37
5.09
8.46
2.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
101
572
2.11
8.32
1.3
1.3
u/ml
3.7
9.4
1.40
41
229
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
9
14.98
8.27
1.4
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
9
14.98
8.27
1.4
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
9
14.98
8.27
1.4
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
13
9
14.98
8.27
1.4
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
46
4.57
8.27
1.4
1.1
u/ml
3.0
4.5
0.40
13
18
(3019150) Specific gravity of Urine by Refractometry
103
589
2.10
8.27
7.6
3.8
kg/l
1.0
1.0
—
5
70
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
56
248
2.52
8.21
2.3
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
51
4.33
8.13
1.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
38
139
2.96
8.03
5.5
4.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
48
4.38
7.85
1.2
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
21
6.41
7.77
1.2
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
17
36
4.93
7.73
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
74
382
2.22
7.65
1.5
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
145
962
1.92
7.49
7.9
7.1
inr
1.2
1.1
0.21
45
304
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
176
2.66
7.38
2.5
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
100
592
2.00
7.16
5.3
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
43
4.37
7.11
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
39
4.55
7.05
2.1
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
27
89
3.22
6.79
2.0
2.1
g/l
1.8
1.6
0.37
21
75
(3020779) Urea [Moles/volume] in Serum or Plasma
41
171
2.60
6.77
6.7
7.6
mmol/l
7.9
8.4
0.19
41
163
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
129
2.83
6.73
5.2
3.8
mmol/l
1.4
1.7
0.24
25
97
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
29
5.00
6.51
2.2
1.6
%
61.0
53.9
—
6
19
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
35
138
2.72
6.45
5.5
3.7
kpa
5.2
5.1
0.10
35
129
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
34
4.58
6.30
2.1
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
68
365
2.09
6.29
2.5
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
30
4.83
6.27
1.9
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
57
3.67
6.26
1.1
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
43
4.12
6.25
2.1
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
140
961
1.81
6.18
4.9
3.3
ng/l
27.1
24.6
0.16
99
610
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
58
3.61
6.11
3.7
2.8
mmol/l
24.3
24.5
0.06
20
50
(3009343) pH of Capillary blood
34
137
2.66
6.01
5.6
3.7
ph
7.4
7.4
—
9
21
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
49
3.83
6.01
2.0
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
6
15.37
5.93
1.7
1.0
—
—
—
0
0
(3020891) Body temperature
26
92
2.99
5.82
5.9
4.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
71
3.25
5.73
1.4
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
117
775
1.80
5.72
4.1
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
38
167
2.45
5.63
1.5
2.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
7
13.18
5.61
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
67
3.28
5.57
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
5
16.34
5.43
2.8
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
5
16.34
5.43
2.8
1.8
%
2.3
10.2
—
8
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
30
4.47
5.34
1.1
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
39
3.98
5.32
3.8
2.7
—
—
—
0
0
(4306422)
15
39
3.98
5.32
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
116
2.65
5.21
1.5
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
110
2.69
5.20
18.7
8.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
23
4.92
5.05
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
23
4.92
5.05
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
23
4.92
5.05
1.1
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
37
170
2.33
4.98
16.0
7.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
18
56
3.34
4.97
3.9
3.4
kpa
6.9
8.4
1.87
18
51
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
59
327
1.98
4.95
3.5
2.2
%
18.8
22.4
1.31
49
278
(3042631) Mycobacterium sp identified in Specimen
13
32
4.19
4.94
2.2
3.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
13
32
4.19
4.94
1.2
1.0
%
89.6
100.3
0.61
13
27
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
184
1428
1.67
4.83
7.0
5.9
umol/l
9.3
9.9
0.75
173
1351
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
15
42
3.70
4.82
1.1
1.1
%
99.9
118.8
1.79
15
37
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
24
4.71
4.82
1.0
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
68
3.07
4.80
2.0
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
109
2.61
4.77
1.8
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
109
2.61
4.77
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
63
3.14
4.75
2.1
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
38
3.81
4.70
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
58
327
1.94
4.62
2.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
271
2358
1.93
4.56
31.2
15.2
%
14.3
13.6
14.25
271
2320
(3012095) Magnesium [Moles/volume] in Serum or Plasma
68
408
1.84
4.48
4.6
3.5
mmol/l
0.8
0.8
0.01
62
390
(3048689) Calprotectin [Mass/mass] in Stool
64
377
1.87
4.47
2.2
2.2
ug/g
235.1
124.4
0.76
57
293
(3022145) Colonoscopy Study observation
57
324
1.92
4.43
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
55
3.21
4.43
2.8
2.3
u/ml
0.5
0.4
0.56
11
32
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
134
2.37
4.31
1.7
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
630
1.69
4.22
2.0
1.7
mg/l
1.2
0.9
0.88
79
488
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
63
2.97
4.13
1.5
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
10
8.17
4.08
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
70
436
1.77
4.06
1.7
1.7
nmol/l
1222.7
1211.9
0.03
61
317
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
99
679
1.66
4.05
1.3
1.3
u/ml
0.5
1.9
1.51
26
203
(3023419) Bacteria identified in Sputum by Culture
11
28
4.03
4.01
3.4
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
48
3.23
3.98
1.5
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
24
4.27
3.91
1.8
1.8
—
—
—
0
0
(4062490)
11
29
3.89
3.83
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
5
12.19
3.77
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
50
3.10
3.74
4.1
2.6
—
—
—
0
0
(4010399)
39
207
2.01
3.68
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
46
3.14
3.57
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
93
2.47
3.57
1.9
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
239
1.92
3.57
2.7
2.3
ml/min/173m2
63.6
68.7
0.40
23
101
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
63
2.79
3.55
1.8
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
26
3.94
3.55
1.3
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
13
6.28
3.52
1.9
4.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
29
142
2.15
3.38
1.1
1.1
titre
—
106.0
—
0
5
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
10
7.13
3.38
1.0
1.1
u/l
10.3
13.1
—
7
10
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
15
54
2.86
3.30
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
28
3.65
3.22
1.8
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
211
1784
1.53
3.21
4.9
4.2
—
169.6
—
0
26
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.44
3.21
2.9
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.44
3.21
2.9
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
15
5.44
3.21
2.9
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
18
73
2.55
3.19
6.3
4.1
mmol/l
3.9
3.8
0.17
18
66
(3026782) Osmolality of Urine
71
477
1.63
3.08
3.1
2.5
mosm/kgh2o
492.0
535.9
1.21
63
411
(3044927) Protein electrophoresis panel - Urine
10
29
3.53
3.07
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
469
1.63
3.07
1.6
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
472
1.62
2.99
4.1
3.6
ng/l
154.5
356.7
0.56
55
338
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
5
10.13
2.99
1.0
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
118
896
1.50
2.97
4.2
3.1
u/l
29.7
29.0
0.15
113
857
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
89
2.33
2.93
1.8
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
160
1295
1.47
2.91
3.9
2.7
ug/l
89.1
89.0
0.00
154
1197
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
133
1039
1.48
2.89
1.9
1.8
pmol/l
90.0
100.5
1.97
73
505
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
9
6.77
2.88
1.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
23
3.99
2.79
1.4
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
121
933
1.47
2.79
2.5
3.4
mmol/l
2.4
2.4
0.37
113
816
(3021960) Folate [Moles/volume] in Serum or Plasma
84
601
1.54
2.77
1.6
1.4
nmol/l
21.1
22.1
0.25
75
494
(1761868) Lipid panel - Serum or Plasma
81
1091
0.66
2.73
2.2
2.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
177
1.90
2.71
2.8
2.4
ug/l
31.9
7.4
0.42
25
156
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
10
6.09
2.71
1.8
1.8
umol/l
26.5
30.5
—
6
10
(3026008) Bacteria identified in Urine by Culture
108
820
1.48
2.67
2.8
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
247
1.76
2.66
5.6
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
254
2275
1.55
2.63
4.7
4.3
pmol/l
15.3
14.6
4.07
241
2097
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.74
2.61
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.74
2.61
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.74
2.61
1.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.74
2.61
1.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
33
3.10
2.55
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
51
2.61
2.47
1.8
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
35
206
1.78
2.46
3.8
3.4
mmol/l
1.3
2.2
0.69
25
162
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
97
2.13
2.43
1.9
1.4
ug/g
229.2
307.4
—
9
59
(21494755) Public health laboratory ask at order entry panel
14
300
0.44
2.41
1.4
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
12
5.07
2.41
2.8
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
40
2.81
2.40
2.3
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
52
2.56
2.39
2.0
2.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
91
2.16
2.38
1.2
1.8
g/l
3.2
3.2
0.00
14
71
(3012544) pH of Venous blood
36
216
1.75
2.38
3.5
3.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
28
3.28
2.32
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
51
339
1.60
2.30
9.8
5.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
18
3.95
2.26
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
30
3.06
2.16
3.0
1.6
—
—
—
0
0
(3013512) EKG study
100
776
1.42
2.15
5.6
3.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
25
3.25
2.11
1.4
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
69
2.23
2.08
2.9
2.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
10
5.06
2.08
1.4
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
140
1.85
2.07
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
20
3.55
2.06
2.6
2.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
20
3.55
2.06
3.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
20
3.55
2.06
1.3
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
97
2.02
2.05
1.2
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
97
2.02
2.05
1.2
1.7
g/l
3.1
3.8
1.98
13
70
(3013826) Glucose [Moles/volume] in Serum or Plasma
174
1491
1.36
2.02
7.8
4.2
mmol/l
6.3
6.5
1.04
167
1384
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
292
1.59
2.01
1.6
2.5
umol/l
4.7
6.5
1.29
38
245
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
64
2.24
1.97
2.4
4.2
—
2.8
—
0
9
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
229
1.64
1.95
2.3
2.4
—
18.5
—
0
9
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
16
3.80
1.94
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
14
65
2.21
1.91
2.5
4.2
mg/l
27.5
23.6
—
9
48
(3034860) Kappa light chains.free [Mass/volume] in Serum
14
65
2.21
1.91
2.5
4.2
mg/l
116.4
36.4
—
9
50
(3037121) Protein [Mass/volume] in Urine
17
86
2.03
1.88
2.0
3.4
g/l
0.5
0.1
—
6
26
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
212
1887
1.36
1.85
3.2
3.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
12
4.21
1.83
2.4
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
23
3.09
1.81
1.1
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
14
67
2.14
1.78
1.2
1.1
e6/l
3.0
4.2
—
9
55
(4094501)
15
74
2.08
1.78
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
36
2.54
1.75
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
49
2.29
1.65
2.5
5.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
49
2.29
1.65
1.5
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
366
1.47
1.65
3.4
2.6
e6/l
6.2
3.7
0.49
34
189
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
14
3.61
1.62
1.0
2.1
ug/l
91.8
57.7
—
5
14
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
50
2.24
1.58
1.6
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
130
1.74
1.57
1.9
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
21
2.89
1.51
1.2
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
103
845
1.32
1.50
2.9
2.3
u/l
58.1
54.6
0.57
94
773
(3022313) Gas panel - Capillary blood
18
102
1.81
1.48
7.3
3.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
45
2.26
1.48
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
45
2.26
1.48
1.7
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
16
3.16
1.44
1.0
1.3
mmol/l
3.1
1.8
—
5
16
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.16
1.44
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
16
3.16
1.44
1.6
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
16
3.16
1.44
5.6
2.9
mu/l
8.8
14.2
—
5
16
(3021788) Differential panel - Synovial fluid
10
46
2.21
1.41
2.0
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
53
2.11
1.40
1.4
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
29
2.44
1.40
3.9
1.2
pg
30.9
32.5
—
7
29
(3000093) Morphology [Interpretation] in Blood Narrative
6
23
2.64
1.37
1.7
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
38
0.00
1.35
0.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
282
2675
1.43
1.32
20.6
11.3
ml/min/173m2
82.3
83.5
0.50
268
2168
(3025941) Bacteria identified in Stool by Culture
27
178
1.56
1.31
1.7
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
44
2.07
1.28
1.4
1.5
—
—
—
0
0
(3019225) pH of Specimen
36
255
1.46
1.27
3.8
3.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
85
1.80
1.25
1.3
2.0
g/l
1.2
0.8
0.15
15
77
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
94
1.74
1.19
1.4
1.3
miu/ml
176.4
271.0
—
7
43
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
38
2.13
1.19
1.5
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
87
1.76
1.17
1.3
2.7
mg/l
11.4
10.2
0.21
15
81
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
279
2654
1.38
1.17
5.6
5.0
mu/l
2.0
2.3
0.33
269
2450
(3019230) Fractional oxyhemoglobin in Venous blood
7
32
2.21
1.08
6.9
1.8
%
70.9
59.8
—
7
32
(3027315) Oxygen [Partial pressure] in Blood
10
52
1.95
1.07
7.8
2.5
kpa
6.4
8.6
—
10
52
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
77
637
1.27
1.04
3.0
2.0
—
—
—
0
0
(44790047)
7
34
2.08
1.03
1.7
1.8
—
—
—
0
0
(44790048)
7
34
2.08
1.03
1.7
1.8
—
—
—
0
0
(44790049)
7
34
2.08
1.03
1.7
1.8
—
—
—
0
0
(44806118)
7
34
2.08
1.03
1.7
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
328
0.68
1.00
1.5
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
23
2.19
0.98
1.4
1.3
—
—
—
0
0
(4035726)
34
252
1.39
0.97
1.7
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
291
0.67
0.96
1.7
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
13
77
1.72
0.96
1.3
1.8
g/l
37.2
37.9
0.19
13
68
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
66
541
1.28
0.96
1.5
1.7
pmol/l
509.8
11136314.3
0.50
58
449
(40768793) Breast Pathology biopsy report
6
118
0.50
0.96
1.8
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
168
1.46
0.93
1.8
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
194
0.60
0.92
2.2
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
29
2.09
0.89
1.5
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
22
309
0.69
0.89
1.2
1.7
%
1.5
1.4
0.26
17
274
(3024928) Oxygen saturation in Venous blood
8
42
1.93
0.89
3.8
2.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
96
1.59
0.86
1.7
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
65
1.72
0.83
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
247
2585
0.81
0.83
4.6
5.3
mmol/mol
37.6
39.0
2.10
233
2415
(42529406) Shigella sp [Presence] in Stool by Culture
15
97
1.57
0.83
1.7
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
97
1.57
0.83
1.7
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
19
131
1.48
0.80
1.5
2.6
u/l
42.7
41.5
0.10
19
115
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
209
0.65
0.78
1.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
289
0.71
0.78
2.1
4.1
ug/l
3.4
7.6
1.39
16
239
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
53
1.72
0.76
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
68
576
1.23
0.76
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
24
2.10
0.75
5.4
3.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
38
1.86
0.74
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
38
1.86
0.74
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
38
1.86
0.74
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
38
1.86
0.74
1.6
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
117
1.48
0.73
4.4
2.6
%
1.1
1.1
0.05
17
117
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
25
2.02
0.73
2.8
3.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
39
1.81
0.73
1.6
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
26
1.94
0.71
2.8
2.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
135
1.43
0.71
16.4
5.9
mmol/l
24.2
25.2
0.70
19
135
(3009542) Hematocrit [Volume Fraction] of Blood
265
2549
1.22
0.67
27.1
13.3
%
39.0
39.9
1.02
172
1912
(3003327) Ova and parasites identified in Stool by Light microscopy
18
128
1.43
0.67
1.9
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
29
1.74
0.64
1.4
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
95
846
1.17
0.63
3.4
2.0
—
—
—
0
0
(4034850)
14
96
1.48
0.62
8.6
9.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
75
655
1.19
0.62
1.5
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
16.5
—
1024.1
—
0
21
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
21.3
—
2015.6
—
0
21
(3013290) Carbon dioxide [Partial pressure] in Blood
8
52
1.55
0.60
8.0
2.5
kpa
5.1
5.1
—
8
52
(3009508) Creatinine [Moles/volume] in Urine
69
787
0.84
0.59
3.5
2.9
mmol/l
7.3
7.1
0.20
64
649
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
6.6
—
0
6
(3020682) Albumin/Creatinine [Ratio] in Urine
67
765
0.84
0.58
4.4
3.8
mg/mmol
20.6
8.1
0.71
44
436
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
32
258
1.27
0.56
4.6
3.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
178
1887
0.87
0.56
3.9
2.9
u/l
60.5
42.5
1.94
166
1771
(40761511) CBC panel - Blood by Automated count
299
2926
1.29
0.55
22.7
11.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
38
1.59
0.54
1.7
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
1.5
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
276
2681
1.20
0.53
3.7
3.9
mmol/l
1.1
1.3
2.79
260
2470
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
794
0.86
0.48
1.5
1.7
mmol/l
1.2
1.4
0.85
64
668
(3002256) Pathology report gross observation
42
358
1.20
0.46
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
139
1297
1.13
0.46
5.4
3.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
50
1.41
0.45
1.6
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
86
1.41
0.45
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
31
1.62
0.43
1.2
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
181
0.76
0.39
2.7
2.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
147
0.74
0.38
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
284
2782
1.17
0.38
4.0
4.3
mmol/l
1.6
1.6
0.99
270
2572
(36660697) Celiac disease serology panel - Serum
28
235
1.21
0.37
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
309
0.83
0.37
1.5
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
121
0.74
0.36
1.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
10
134
0.74
0.35
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
154
1.25
0.34
1.0
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
16
128
1.26
0.32
2.0
2.5
e6/l
0.1
0.1
0.12
16
122
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
284
2793
1.14
0.29
4.2
4.4
mmol/l
4.6
4.9
3.75
270
2595
(3012516) Albumin [Mass/volume] in Urine
67
725
0.90
0.28
3.6
3.1
mg/l
2837.2
249.1
0.98
45
417
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
72
1.26
0.26
1.6
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
77
1.17
0.24
1.0
1.1
—
8.5
—
0
13
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
105.4
—
0
5
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
136.9
—
0
11
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
114.8
—
0
5
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
11.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1868.0
—
0
10
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
276
2720
1.10
0.21
4.0
4.4
mmol/l
5.6
5.8
3.76
261
2511
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
23.4
—
0
12
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.8
—
7.6
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4198724)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
126
1210
1.07
0.20
2.3
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
136
1.19
0.20
1.6
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.3
—
39.2
—
0
9
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
52
1.16
0.19
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
358
1.10
0.18
4.1
4.4
%
33.7
33.3
0.08
32
227
(3050129) First trimester maternal screen panel - Serum or Plasma
6
78
0.76
0.15
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
80
0.75
0.15
1.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
83
1.09
0.15
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
20
222
0.89
0.14
2.3
4.0
%
18.9
21.8
—
8
102
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
209
1.11
0.13
1.1
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
46
1.09
0.09
4.8
1.2
nmol/l
0.7
1.0
—
5
38
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
278
0.93
0.09
1.3
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
58
1.04
0.08
1.8
2.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
65
0.77
0.08
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
65
0.77
0.08
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
65
0.77
0.08
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
65
0.77
0.08
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
77
749
1.04
0.07
1.4
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
85
0.82
0.07
1.1
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
102
0.88
0.06
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
292
0.96
0.04
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
160
0.93
0.04
2.1
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
16
170
0.94
0.04
1.7
2.6
ug/l
0.4
0.8
—
9
105
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
285
2842
1.02
0.01
4.5
4.9
mmol/l
2.6
2.9
6.04
271
2625
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
98
1.02
0.00
1.4
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
20
198
1.01
0.00
1.6
3.2
pmol/l
4.4
4.5
0.18
15
177
(3019832) Treponema pallidum Ab [Presence] in Serum
24
243
0.99
0.00
1.1
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
125
0.96
0.00
1.7
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
125
0.96
0.00
3.1
3.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
108.5
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
60
1.00
0.00
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
59
0.85
0.00
2.8
4.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
85
0.94
0.00
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
79
0.88
0.00
1.1
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
(3049717) Cytology report of Urine Cyto stain
7
70
1.00
0.00
1.3
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
85
0.94
0.00
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
55
0.91
0.00
2.8
2.5
mmol/l
1.5
1.4
—
5
55
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
16.3
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
80
1.00
0.00
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
69
0.87
0.00
1.2
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint SYSTSCLE_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| SYSTSCLE_STRICT | 2.104 [1.69, 2.63] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.582 |
During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 823 females with SYSTSCLE_STRICT died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have SYSTSCLE_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.201% | No data |
| 5 | 1.155% | No data |
| 10 | 3.086% | No data |
| 15 | 6.121% | No data |
| 20 | 10.651% | No data |
Relationships between endpoints
↥Index endpoint: SYSTSCLE_STRICT – Systemic sclerosis,strict definition
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data